This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

On-Pump vs. Off-Pump CABG in High-Risk Patients (EuroSCORE 6+) (PRAGUE 6+)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2008 by Charles University, Czech Republic.
Recruitment status was:  Enrolling by invitation
Information provided by:
Charles University, Czech Republic Identifier:
First received: January 22, 2008
Last updated: NA
Last verified: January 2008
History: No changes posted
Previous studies comparing on-pump and off-pump operating strategy did only partially demonstrate benefits of the off-pump myocardial revascularisation.In primary end-points (MI, death, renal failure, and so on) there was no significant difference, but in secondary end-points we observed benefits resulting for patients. We would like to show the benefit of the method without extracorporeal circulation in patients with higher and hight operation risk, coming from EuroSCORE classification system (6 points and more).

Condition Intervention
Ischemic Heart Disease Post-Operative Complications Procedure: OPCAB - the off-pump coronary artery bypass

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Aortocoronary Bypasses in High-Risk Patients (EuroSCORE 6+) With or Without Use of the Cardio-Pulmonary Bypass.

Resource links provided by NLM:

Further study details as provided by Charles University, Czech Republic:

Primary Outcome Measures:
  • death, heart stroke, brain stroke, renal failure, early reoperation [ Time Frame: 30 days ]
  • heart stroke, brain stroke, death, renal failure, early reoperation [ Time Frame: 30 days and 365 days ]

Secondary Outcome Measures:
  • length of in-hospital stay, blood losses, number of blood-transfusion, new appeared atrial fibrillation, 1-year mortality, quality of life-angina classified by CCS in 1-year follow up, length of mechanical ventilation [ Time Frame: 30 days and 365 days ]

Estimated Enrollment: 220
Study Start Date: June 2006
Estimated Study Completion Date: December 2009
Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients with ischemic heart disease, with EuroSCORE 6 additive points and more, operated with use of the cardio-pulmonary bypass
Patients with ischemic heart disease, with EuroSCORE 6 additive points and more, operated without use of the cardio-pulmonary bypass
Procedure: OPCAB - the off-pump coronary artery bypass
surgical myocardial revascularisation without use of cardio-pulmonary bypass, using stabilising devices on beating heart


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
People indicated for surgical myocardial revascularisation with high surgical risk

Inclusion Criteria:

  • stable form of ischemic heart disease
  • unstable angina pectoris
  • acute myocardial infarction
  • additive EuroSCORE 6 and more
  • informed approval of the patient

Exclusion Criteria:

  • significant heart valve disease, requesting surgery
  • aortic aneurysm requesting surgery
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00606372

Czech Republic
Kralovske Vinohrady University Hospital
Prague, Czech Republic, 10034
2nd Surgical Dpt. of 1st Faculty of Medicine of Charles University, Prague
Prague, Czech Republic, 11000
Sponsors and Collaborators
Charles University, Czech Republic
Principal Investigator: Zbynek Straka, 1 Charles University, Prague
  More Information

Responsible Party: Prof. MUDr. Zbynek Straka, CSc., Kralovske Vinohrady University Hospital Identifier: NCT00606372     History of Changes
Other Study ID Numbers: 240376
Study First Received: January 22, 2008
Last Updated: January 22, 2008

Keywords provided by Charles University, Czech Republic:
high-risk patients
Quality of life
Validity of EuroSCORE

Additional relevant MeSH terms:
Heart Diseases
Myocardial Ischemia
Coronary Artery Disease
Postoperative Complications
Cardiovascular Diseases
Vascular Diseases
Coronary Disease
Arterial Occlusive Diseases
Pathologic Processes processed this record on August 22, 2017